NADPH oxidase-derived ROS: Key modulators of heme-induced mitochondrial stability in human neutrophils

Experimental Cell Research

Volumn 312, Issue 19, 2006, Pages 3939-3948

  Arruda, Maria Augusta ^a   Barcellos de Souza, Pedro ^a   Sampaio, André Luiz Franco ^b   Rossi, Adriano G ^c   Graça Souza, Aurélio V ^d   Barja Fidalgo, Christina ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Apoptosis; Bcl 2 family proteins; Heme; Mitochondria; NADPH oxidase; Neutrophil; Oxidative stress; Signal transduction

Indexed keywords

HEME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME MECHANISM; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOCHONDRION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

EID: 33750354299     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.08.022     Document Type: Article

References (36)

1. Chanock S.J., el Benna J., Smith R.M., and Babior B.M. The respiratory burst oxidase. J. Biol. Chem. 269 (1994) 24519-24522
2. Chiarugi P. PTPs versus PTKs: the redox side of the coin. Free Radical Res. 39 (2005) 353-364
3. Dewald B., and Baggiolini M. Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. Biochem. Biophys. Res. Commun. 128 (1985) 297-304
4. Jones S.A., Wolf M., Qin S., Mackay C.R., and Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6682-6686
5. Graça-Souza A.V., Arruda M.A., de Freitas M.S., Barja-Fidalgo C., and Oliveira P.L. Neutrophil activation by heme: implications for inflammatory processes. Blood 99 (2002) 4160-4165
6. Arruda M.A., Rossi A.G., de Freitas M.S., Barja-Fidalgo C., and Graça-Souza A.V. Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J. Immunol. 173 (2004) 2023-2030
7. Ward C., Chilvers E.R., Lawson M.F., Pryde J.G., Fujihara S., Farrow S.N., Haslett C., and Rossi A.G. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274 (1999) 4309-4318
8. Mayadas T.N., and Cullere X. Neutrophil beta2 integrins: moderators of life or death decisions. Trends Immunol. 26 (2005) 388-395
9. Newmeyer D.D., and Fregusson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112 (2003) 481-490
10. Borregaard N., and Herlin T. Energy metabolism of human neutrophils during phagocytosis. J. Clin. Invest. 70 (1982) 550-557
11. Maianski N.A., Roos D.A., and Kuijpers T.W. Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 101 (2003) 1987-1995
12. Maianski N.A., Geissler J., Srinivasula S.M., Alnemri E.S., Roos D., and Kuijpers T.W. Functional characterization of neutrophil mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 11 (2004) 143-153
13. Rapp U.R., Rennefahrt U., and Troppmair J. Bcl-2 proteins: master switches at the intersection of death signaling and the survival control by Raf kinases. Biochim. Biphys. Acta 1644 (2004) 149-158
14. Klein J.B., Rane M.J., Scherzer J.A., Coxon P.Y., Kettritz R., Mathiesen J.M., Buridi A., and McLeish K.R. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 164 (2000) 4286-4291
15. Klein J.B., Buridi A., Coxon P.Y., Rane M.J., Manning T., Kettritz R., and McLeish K.R. Role of extracellular signal-regulated kinase and phosphatidylinositol-3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis. Cell Signalling 13 (2001) 335-343
16. Akgul C., Moulding D.A., and Edwards S.W. Molecular control of neutrophil apoptosis. FEBS Lett. 487 (2001) 318-322
17. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 5 (1976) 9-15
18. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., and Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 (1995) 961-973
19. Bradford M. Rapid and sensitive method for quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
20. Muller-Eberhard U., and Fraig M. Bioactivity of heme and its containment. Am. J. Hematol. 42 (1993) 59-62
21. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., CannonIII R.O., Schechter A.N., and Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8 (2002) 1383-1389
22. Davenport R.D., Strieter R.M., Standiford T.J., and Kunkel S.L. Interleukin-8 production in red blood cell incompatibility. Blood 76 (1990) 2439-2442
23. Davenport R.D., and Kunkel S.L. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus. Med. Rev. 8 (1994) 157-168
24. Mollapour E., Porter J.B., Kaczmarski R., Linch D.C., and Roberts P.J. Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease. Blood 91 (1998) 3423-3429
25. Gonçalves M.S., Queiroz I.L., Cardoso S.A., Zanetti A., Strapazoni A.C., Adorno E., Albuquerque A., Sant'Ana A., dos Reis M.G., Barral A., and Barral Netto M. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz. J. Med. Biol. Res. 34 (2001) 1309-1313
26. Wun T. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematol. 5 (2001) 403-412
27. Kaul D.K., and Hebbel R.P. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J. Clin. Invest. 106 (2000) 411-420
28. Wagener F.A., Abraham N.G., van Kooyk Y., de Witte T., and Figdor C.G. Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation. Trends Pharmacol. Sci. 22 (2001) 52-54
29. Watson R.W. Redox regulation of neutrophil apoptosis. Antioxid. Redox Signal. 4 (2002) 97-104
30. Zhang B., Hirahashi J., Cullere X., and Mayadas T.N. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J. Biol. Chem. 278 (2003) 28443-28454
31. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., and Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172 (2004) 2522-2529
32. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
33. Aggarwal B.B. Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. Biochem. Pharmacol. 60 (2000) 1033-1039
34. Haddad J.J. Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-kappaB. Crit. Care 6 (2002) 481-490
35. Gilroy D.W., Lawrence T., Perretti M., and Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev., Drug Discov. 3 (2004) 401-416
36. Lawrence T., Gilroy D.W., Colville-Nash P.R., and Willoughby D.A. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7 (2001) 1291-1297